Australia's largest stock trading and investment forum Australia's #1 stock forum

AN1

Click for more information

0.00%

0.8¢ anagenics limited

QBiotics v Cellmid, page-2

First 2 Last

Share
Profile

Follow
aussie1943

301 Posts.

15/08/16

20:45

Post #: 18522984
Share

Originally posted by Trae ↑

Made from the north Queensland’s blushwood tree berries, QBiotics breakthrough cancer fighting EBC-46 drug for solid tumours has just received ethical approval for human trials.
Until now, EBC-46 has been administered through veterinary clinics with demonstrations on TV tonight showing it's effects on dogs.

Sound familiar?

CDY has a product that produces better results on cancer then chemotherapy & in vetrinary testing (Zoetis in CDY's case).
I see CDY's IP as having an advantage in that it will target small cancers that are not yet discovered to be injected with a syringe.

Between this & CDY's recent results reversing osteoporosis, there should be a little more international & big pharma attention on small ozzie bio.

Expand

We just need more analysts big name ones to do articles on this company from what I see of it nobody knows about it that is one major problem . Not just the ones that have been mentioned on this site before

CDY Price at posting: 3.3¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RXL

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 7 more messages in this thread...

First 2 Last

Add AN1 (ASX) to my watchlist